Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marlies J W, Peeters"'
Autor:
Thomas Morgan Hulen, Christina Friese, Nikolaj Pagh Kristensen, Joachim Stoltenborg Granhøj, Troels Holz Borch, Marlies J. W. Peeters, Marco Donia, Mads Hald Andersen, Sine Reker Hadrup, Inge Marie Svane, Özcan Met
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/ef1231a8b35045258c3dac4c45de3bd2
Autor:
Thomas Morgan Hulen, Christina Friese, Nikolaj Pagh Kristensen, Joachim Stoltenborg Granhøj, Troels Holz Borch, Marlies J. W. Peeters, Marco Donia, Mads Hald Andersen, Sine Reker Hadrup, Inge Marie Svane, Özcan Met
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Checkpoint inhibition (CPI) therapy and adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TIL-based ACT) are the two most effective immunotherapies for the treatment of metastatic melanoma. While CPI has been the dominating therap
Externí odkaz:
https://doaj.org/article/7afe16c86d48470cacf63c8ae355b95e
Autor:
Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Per thor Straten
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/593b961b919e482caa28a6ae47f86f5f
Autor:
Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Per thor Straten
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Myeloproliferative neoplasms (MPN) are chronic cancers of the hematopoietic stem cells in the bone marrow, and patients often harbor elevated numbers of circulating platelets (PLT). We investigated the frequencies of circulating PLT-lymphocyte aggreg
Externí odkaz:
https://doaj.org/article/4d831d41a2bb43238209bbff284b2564
Autor:
Marlies J. W. Peeters, Pia Aehnlich, Adriano Pizzella, Kasper Mølgaard, Tina Seremet, Özcan Met, Lene Juel Rasmussen, Per thor Straten, Claus Desler
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
T-cell activation upon antigen stimulation is essential for the continuation of the adaptive immune response. Impairment of mitochondrial oxidative phosphorylation is a well-known disruptor of T-cell activation. Dihydroorotate dehydrogenase (DHODH) i
Externí odkaz:
https://doaj.org/article/d07890576b8949e18e9b8caa7c3ef5cf
Autor:
Richard M. Powell, Marlies J. W. Peeters, Anne Rahbech, Pia Aehnlich, Tina Seremet, Per thor Straten
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1294 (2021)
There is an increasing interest in the development of Receptor Tyrosine Kinases inhibitors (RTKIs) for cancer treatment, as dysregulation of RTK expression can govern oncogenesis. Among the newer generations of RTKIs, many target Mer Tyrosine Kinase
Externí odkaz:
https://doaj.org/article/ea4b29a1d4364e7390284cee2fd8917d
Publikováno v:
Immunometabolism. 5:e00019
Autor:
Marlies J W, Peeters, Pia, Aehnlich, Adriano, Pizzella, Kasper, Mølgaard, Tina, Seremet, Özcan, Met, Lene Juel, Rasmussen, Per, Thor Straten, Claus, Desler
Publikováno v:
Frontiers in Immunology
T-cell activation upon antigen stimulation is essential for the continuation of the adaptive immune response. Impairment of mitochondrial oxidative phosphorylation is a well-known disruptor of T-cell activation. Dihydroorotate dehydrogenase (DHODH) i
Autor:
Marlies J W, Peeters, Donata, Dulkeviciute, Arianna, Draghi, Cathrin, Ritter, Anne, Rahbech, Signe K, Skadborg, Tina, Seremet, Ana Micaela, Carnaz Simões, Evelina, Martinenaite, Hólmfridur R, Halldórsdóttir, Mads Hald, Andersen, Gitte Holmen, Olofsson, Inge Marie, Svane, Lene Juel, Rasmussen, Özcan, Met, Jürgen C, Becker, Marco, Donia, Claus, Desler, Per, Thor Straten
Publikováno v:
Cancer immunology research. 7(9)
The TAM family of receptor tyrosine kinases (TYRO3, AXL, and MERTK) is known to be expressed on antigen-presenting cells and function as oncogenic drivers and as inhibitors of inflammatory responses. Both human and mouse CD8